acquired
Stage
2010
Founded
3
Investors
About
Gyroscope Therapeutics is a clinical-stage gene therapy company focused on developing gene therapies for eye diseases, particularly geographic atrophy secondary to age-related macular degeneration (AMD). Its lead investigational therapy, GT005, aims to restore balance to an overactive complement system within the eye.
Explore Gyroscope Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.